Dx Deals: Outreach Deals by Quest, Labcorp Are Still Ramping Up
Though the two national players have closed dozens of such deals over the past decade, much runway for new transactions apparently remains
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Though the two national players have closed dozens of such deals over the past decade, much runway for new transactions apparently remains
From - G2 Compliance Advisor
Patient health information breaches—whether from hacking, glitches or just plain old carelessness…
From - Laboratory Industry Report
A notable FDA Section 510(k) approval was granted before the close of 2016 for Foundation Medicine's FoundationFocus CDxBRCA, a next-generation sequencing-based companion diagnostic test…
From - Diagnostic Testing & Emerging Technologies
Advanced diagnostic tests are emerging faster than the clinicians can document their clinical utility. All of this creates an interesting dilemma for…
From - National Intelligence Report
Just as the civil monetary penalties have gotten an update to adjust for inflation so too have the thresholds for…
From - G2 Compliance Advisor
If your lab performs sleep studies on Medicare patients, beware. It is now a high-priority target for federal fraud and…
From - Laboratory Industry Report
Although volume of diagnostics industry mergers and acquisitions was up slightly in 2016, the big story of the year were the deals that…
From - National Intelligence Report
As we closed out the calendar year, the U.S. Department of Justice (DOJ) reflected on its successes for the fiscal year 2016 (FY 2016) which ended…
From - G2 Compliance Advisor
One aspect of the Affordable Care Act (ACA) that is not likely to be repealed is the enhancement of penalties for Medicare and Medicaid fraud and abuse. That includes…